Goldman Sachs’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $31K | Buy |
|
|||||
|
2018
Q2 | $31K | Buy |
|
|||||
|
2018
Q1 | $48K | Buy |
|
|||||
|
2017
Q4 | $48K | Sell |
|
|||||
|
2017
Q3 | $109K | Sell |
|
|||||
|
2017
Q2 | $152K | Sell |
|
|||||
|
2017
Q1 | $200K | Sell |
|
|||||
|
2016
Q4 | $521K | Sell |
|
|||||
|
2016
Q3 | $936K | Sell |
|
|||||
|
2016
Q2 | $2.27M | Buy |
|
|||||
|
2016
Q1 | $3.41M | Sell |
|
|||||
|
2015
Q4 | $5.18M | Sell |
|
|||||
|
2015
Q3 | $9.03M | Sell |
|
|||||
|
2015
Q2 | $6.76M | Buy |
|
|||||
|
2015
Q1 | $5.12M | Buy |
|
|||||
|
2014
Q4 | $177K | Buy |
|
|||||
|
2014
Q3 | $26K | Sell |
|
|||||
|
2014
Q2 | $61K | Sell |
|
|||||
|
2014
Q1 | $144K | Buy |
|
|||||
|
2013
Q4 | $137K | Buy |
|
|||||
|
2013
Q3 | $124K | Sell |
|
|||||
|
2013
Q2 | $236K | Buy |
|